Study of the safety and tolerability of
Study of the safety and tolerability of Simulect® (basiliximab) versus OKT3 in heart transplantation
✍
M.G. Crespo-Leiro; J.L. Rodriguez-Lambert; J.L. Segovia; L. Almenar; E. Roig; M.
📂
Article
📅
2003
🏛
Elsevier Science
🌐
English
⚖ 52 KB